Premier Wab Kinew and Health Minister Uzoma Asagwara release audited workforce statistics showing a net addition of 4,700 nurses, doctors, and support staff across regional health authorities.

WINNIPEG, MB — Premier Wab Kinew and Health Minister Uzoma Asagwara released verified provincial workforce health data Wednesday confirming a net increase of more than 4,700 frontline healthcare professionals across Manitoba since late 2023.
The audited figures, verified by Shared Health Manitoba, encompass registered nurses, licensed practical nurses, family physicians, emergency paramedics, and clinical health care aides. The growth reflects the deployment of $200 million in retention bonuses, rural and northern isolation premiums, and the creation of the Manitoba Healthcare Recruitment Task Force, which streamlined credential recognition for internationally trained clinical practitioners.
Rural health authorities, including Southern Health-Santé Sud and Prairie Mountain Health, recorded significant reductions in mandatory nurse overtime hours and temporary emergency room rolling closures.
Premier Kinew also highlighted the ongoing deployment of a temporary modular emergency department at Dauphin Regional Health Centre, ensuring uninterrupted critical trauma and acute care following localized facility water damage earlier this month.
Healthcare union leadership, including the Manitoba Nurses Union (MNU), recognized the staffing progress while calling for continued investments in mentorship ratios and workplace safety protocols across acute-care wards.
The Department of Health will publish its next quarterly staffing accountability audit in November 2026, including specialized metrics on surgical wait time reductions.

Manitoba Premier Wab Kinew details a $12 million rehabilitation plan for Dauphin Regional Health Centre, expanding surgical capacity and restoring flood-damaged facilities.

Biomedical researchers report significant disease-free survival metrics in late-stage melanoma trials, prompting expedited regulatory review requests.

President Donald Trump nominates Dr. Heidi Overton to lead the FDA, setting up a Senate confirmation battle over pharmaceutical regulations and agency reform.